NCT02302404: A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects |
|
|
| Completed | 1 | 79 | Europe | GSK2982772 solution, GSK2982772 capsule, Placebo solution, Placebo capsule | GlaxoSmithKline, Clinical Unit at Cambridge (Addenbrooks) | Inflammatory Bowel Diseases | 03/16 | 03/16 | | |
